| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.5M | — | +7.8% |
| Cost of Revenue | $18.3M | — | +12.7% |
| Gross Profit | $16.2M | — | +2.6% |
| R&D Expense | $1.4M | — | -15.6% |
| SG&A Expense | $13.0M | — | -0.7% |
| Operating Income | -$9.0M | — | +18.3% |
| Interest Expense | $2.3M | — | +17.9% |
| Net Income | -$10.8M | — | +14.9% |
| EPS (Basic) | -$0.16 | — | +23.8% |
| EPS (Diluted) | -$0.16 | — | +23.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.2M | -53.0% | -34.7% |
| Accounts Receivable | $15.8M | -4.0% | -39.7% |
| Inventory | $4.7M | +9.0% | +15.9% |
| Current Assets | $47.2M | -23.4% | -22.2% |
| Total Assets | $125.4M | -11.4% | -11.7% |
| Current Liabilities | $28.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.4M | — | +44.6% |
| Investing Cash Flow | -$172K | — | +21.5% |
| Financing Cash Flow | -$5.6M | — | -129.4% |
| +13.9% |
| Long-term Debt | $61.3M | -6.9% | +10.8% |
| Total Liabilities | $108.4M | -6.0% | +5.8% |
| Stockholders' Equity | $13.3M | -40.7% | -62.6% |